Whitehawk Therapeutics, Inc.
DE ˙ DB ˙ US00032Q1040
3,64 € ↑0,20 (5,81%)
2026-06-04
CENA AKCJI
SecurityDE:3350 / Whitehawk Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership8,342 shares
Latest Disclosed Value $ 28,780
Morgan Stanley reports 23.62% increase in ownership of 3350 / Whitehawk Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 8,342 shares of Whitehawk Therapeutics, Inc. (DE:3350) valued at $23,191 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 6,748 shares of Whitehawk Therapeutics, Inc.. This represents a change in shares of 23.62% during the quarter. The current value of the position is $30,365 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F WHITEHAWK THERAPEUTICS COM 00032Q104 8,342 1,594 23.62 29 75.00 0.0000
2026-05-27 2025-12-31 13F/A-1 WHITEHAWK THERAPEUTICS COM 00032Q104 6,748 4,899 264.95 16 433.33 0.0000
2026-02-13 2025-12-31 13F WHITEHAWK THERAPEUTICS COM 00032Q104 6,748 4,899 16 0.0000
2026-05-27 2025-09-30 13F/A-1 WHITEHAWK THERAPEUTICS COM 00032Q104 1,849 -154 -7.69 4 0.00 0.0000
2025-11-14 2025-09-30 13F WHITEHAWK THERAPEUTICS COM 00032Q104 1,849 -154 4 0.0000
2025-08-15 2025-06-30 13F WHITEHAWK THERAPEUTICS COM 00032Q104 2,003 -62,234 -96.88 4 -97.37 0.0000
2025-05-15 2025-03-31 13F WHITEHAWK THERAPEUTICS COM 00032Q104 64,237 51,476 403.39 114 185.00 0.0000
2025-05-15 2024-12-31 13F/A-1 AADI BIOSCIENCE COM 00032Q104 12,761 10,350 429.28 40 900.00 0.0000
2025-02-14 2024-12-31 13F AADI BIOSCIENCE COM 00032Q104 12,761 10,350 40 0.0000
2025-05-14 2024-09-30 13F/A-2 AADI BIOSCIENCE COM 00032Q104 2,411 -62,493 -96.29 5 -95.74 0.0000
2025-02-14 2024-09-30 13F/A-1 AADI BIOSCIENCE COM 00032Q104 2,411 -62,493 5 0.0000
2024-11-14 2024-09-30 13F AADI BIOSCIENCE COM 00032Q104 2,411 -62,493 5 0.0000
2025-05-14 2024-06-30 13F/A-2 AADI BIOSCIENCE COM 00032Q104 64,904 -399,562 -86.03 95 -91.34 0.0000
2024-10-17 2024-06-30 13F/A-1 AADI BIOSCIENCE COM 00032Q104 64,904 -399,562 95 0.0000
2024-08-14 2024-06-30 13F AADI BIOSCIENCE COM 00032Q104 64,904 -399,562 95 0.0000
2024-10-17 2024-03-31 13F/A-2 AADI BIOSCIENCE COM 00032Q104 464,466 -46,205 -9.05 1,087 5.33 0.0001
2024-08-16 2024-03-31 13F/A-1 AADI BIOSCIENCE COM 00032Q104 464,466 -46,205 1,087 0.0001
2024-05-15 2024-03-31 13F AADI BIOSCIENCE COM 00032Q104 464,466 -46,205 1,087 0.0001
2024-08-16 2023-12-31 13F/A-1 AADI BIOSCIENCE COM 00032Q104 510,671 291,528 133.03 1,032 -2.74 0.0001
2024-02-13 2023-12-31 13F AADI BIOSCIENCE COM 00032Q104 510,671 291,528 1,032 0.0001
2023-11-15 2023-09-30 13F AADI BIOSCIENCE COM 00032Q104 219,143 121,434 124.28 1,061 58.68 0.0001
2023-08-14 2023-06-30 13F AADI BIOSCIENCE COM 00032Q104 97,709 79,850 447.11 668 417.83 0.0001
2023-05-15 2023-03-31 13F AADI BIOSCIENCE COM 00032Q104 17,859 15,165 562.92 129 279.41 0.0000
2023-02-14 2022-12-31 13F AADI BIOSCIENCE COM 00032Q104 2,694 -6,313 -70.09 35 -73.23 0.0000
2022-11-14 2022-09-30 13F AADI BIOSCIENCE COM 00032Q104 9,007 -14,218 -61.22 127 -55.59 0.0000
2022-10-27 2022-06-30 13F/A-1 AADI BIOSCIENCE COM 00032Q104 23,225 -12,593 -35.16 286 -52.96 0.0000
2022-08-15 2022-06-30 13F AADI BIOSCIENCE COM 00032Q104 23,225 -12,593 286 0.0000
2022-10-27 2022-03-31 13F/A-1 AADI BIOSCIENCE COM 00032Q104 35,818 33,127 1,231.03 608 835.38 0.0001
2022-05-13 2022-03-31 13F AADI BIOSCIENCE COM 00032Q104 35,818 33,127 608 0.0001
2022-02-14 2021-12-31 13F AADI BIOSCIENCE COM 00032Q104 2,691 2,600 2,857.14 65 2,066.67 0.0000
2021-11-15 2021-09-30 13F AADI BIOSCIENCES COM 00032Q104 91 91 3 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.